Search

everythinglearnresearchcommunity

for

Search:↓

The model successfully simulates human hair growth and patterns, including hair loss types.

Common hair loss can be diagnosed with a physical exam and sometimes a hair test or skin biopsy, and treated with medication or surgery, with ongoing treatment needed to keep results.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Androgenetic alopecia is a common hair thinning condition linked to genetics and hormones.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

TrichoScan effectively measures hair growth improvements in people using minoxidil.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

New treatments are needed for hair loss, and cell therapies might reverse hair thinning.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Changing hair follicle identity could potentially reverse balding.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Wnt10b makes hair follicles bigger, but DKK1 can reverse this effect.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Androgenetic alopecia is common hair loss due to genetics and DHT.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Hormones, especially DHT, affect hair loss and growth, and targeting specific enzymes may help treat hair loss.

A gene mutation causes woolly hair in a Syrian patient.